A detailed history of Platinum Investment Management LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Platinum Investment Management LTD holds 370,159 shares of ABBV stock, worth $86.6 Million. This represents 6.0% of its overall portfolio holdings.

Number of Shares
370,159
Previous 365,440 1.29%
Holding current value
$86.6 Million
Previous $67.8 Million 26.35%
% of portfolio
6.0%
Previous 4.86%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$184.85 - $231.54 $872,307 - $1.09 Million
4,719 Added 1.29%
370,159 $85.7 Million
Q2 2025

Jul 18, 2025

SELL
$170.16 - $206.27 $9.01 Million - $10.9 Million
-52,927 Reduced 12.65%
365,440 $67.8 Million
Q1 2025

May 15, 2025

BUY
$169.2 - $216.66 $70.8 Million - $90.6 Million
418,367 New
418,367 $87.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.